Expression and Purification of Staphylococcal Enterotoxin B and Detection of SEB-Specific IgG Antibodies in Allergic Children.

Authors

Huixin Gao, Yuqian Yan, Qingling Ma, Xiaolan Ai, Hao Zheng, Zhenwen Zhou, Yunfeng Liu

Published in

American journal of rhinology & allergy. Pages 19458924261493373. Oct 09, 2026. Epub Oct 09, 2026.

Abstract

ObjectiveThis study aims to express and purify staphylococcal enterotoxin B (SEB) and to detect and analyze the levels of SEB-specific IgG antibodies in the serum of children with food or aeroallergen allergies using an enzyme-linked immunosorbent assay (ELISA).MethodsSEB protein was expressed and purified in a recombinant pET-28α(+)-SEB E. coli system. The purified SEB protein was used as an antigen to detect SEB-IgG antibody levels in the serum of 100 clinically confirmed cases of food-allergic and aeroallergen-allergic children, and the results were compared with those of 50 healthy children using ELISA.ResultsThe recombinant SEB protein, with a molecular weight of approximately 35 kDa, was successfully expressed and purified. ELISA results showed that the SEB-IgG antibody levels in the serum of food-allergic and aeroallergen-allergic children (OD450 values of 0.30 ± 0.03 and 0.31 ± 0.04, respectively) were significantly higher than those in the normal control group (0.24 ± 0.05, P < .05). However, there was no significant difference in SEB-IgG antibody levels between food-allergic children and aeroallergen-allergic children (P > .05). The positive rate of SEB-IgG antibodies was 68% in aeroallergen-allergic children and 56% in food-allergic children. SEB-IgG positivity increased with the number of allergens but was not correlated with the severity of the allergy.ConclusionThis study successfully expressed and purified SEB protein in a prokaryotic system. We found that SEB-IgG antibody levels were significantly higher in allergic children compared to healthy controls and were related to the number of allergens. These results suggest an association between SEB exposure and allergic diseases in the pediatric population, highlighting its potential role as an immunomodulator and laying a foundation for further mechanistic and clinical investigations.

PMID:
42852902
Bibliographic data and abstract were imported from PubMed on 09 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.